• Home
  • Medinfo
  • Storage of CellCept Outside of the Original Packaging

Storage of CellCept Outside of the Original Packaging

This letter responds to your request for information on storage of CellCept® (mycophenolate mofetil) tablets and capsules outside of the original blister and carton packaging.

Download article Download

Last updated August 12, 2023

Rationale for use of the original packaging

CellCept tablets and capsules must be stored in the original blister package within the outer carton to protect from moisture and light.[1]

Stability and compatibility considerations

Stability and compatibility of CellCept can only be guaranteed for the original packaging that have been manufactured and packaged under validated conditions and approved with the relevant marketing authorization application.

The stability and compatibility of primary packaged CellCept cannot be transferred to repackaged products in the blistering process due to variable conditions such as

  • temperature
    • air humidity
      • light permeability
        • chemical interactions, and
          • duration of re-packaging process.[2,3]
                

            We have no data on the storage of CellCept tablets or capsules outside of the original primary packaging (blister and outer carton).

            References

            1. Roche Internal Technical Report (Accessed on 28 June 2023).
              1. Roche Internal Communication (Accessed on 26 Jun 2023).
                1. Roche Internal Communication (Accessed on 9 Aug 2023).

                  Welcome to Medically

                  The Roche Science Hub

                  This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

                  Not a healthcare professional? Browse:

                  This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

                  You are Leaving Medically

                  By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.